Corrigendum to “Pharmacotherapy for amphetamine dependence: A systematic review” [Drug Alcohol Depend. 191 (2018) 309–337] (Drug and Alcohol Dependence (2018) 191 (309–337), (S0376871618304599) (10.1016/j.drugalcdep.2018.06.038))
MetadataShow full item record
© 2018 The authors regret, that there is an error in the ‘results’ section of the abstract of this paper. The medication buprenorphine was incorrectly listed instead of bupropion, as being one of four medications demonstrating some limited evidence for reducing amphetamine use. The corrected version of this sentence is as follows: “Four of these medicines demonstrated some limited evidence of benefit for reducing amphetamine use: methylphenidate (as reported in three studies), bupropion (in three studies), modafinil (two studies), and naltrexone (one study)”. The authors would like to apologise for any inconvenience caused.
Showing items related by title, author, creator and subject.
Awange, Joseph; Saleem, Ashty; Sukhadiya, R.; Ouma, Y.; Kexiang, H. (2019)© 2018 Elsevier B.V. Understanding changes in the physical dynamics of lakes (e.g., areas and shorelines) is important to inform policies, planning and management during climate extremes (e.g., floods and droughts). For ...
Exploring patients’ and healthcare professionals’ experiences of patient-witnessed resuscitation: A qualitative study protocolFiori, M.; Endacott, R.; Latour, Jos (2018)© 2018 John Wiley & Sons Ltd Aim: The aim of this study was to explore the experiences of patients and healthcare professionals regarding patients witnessing resuscitation on another patient in hospital clinical wards. ...
Finn, Judith; Jacobs, I.; Williams, T.; Gates, S.; Perkins, G. (2019)© 2019 The Cochrane Collaboration. Background: Adrenaline and vasopressin are widely used to treat people with cardiac arrest, but there is uncertainty about the safety, effectiveness and the optimal dose. Objectives: To ...